Life Science Company
Aegerion Pharmaceuticals has acquired 1 company of its own.
Aegerion Pharmaceuticals’ largest acquisition to date was in 2014, when it acquired Myalept for $325M. Aegerion Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).
Join Mergr and gain access to Aegerion Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1